Patents by Inventor Bernd Buchberger
Bernd Buchberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11098298Abstract: The present invention provides a novel method for the recombinant production of Factor C protein from horseshoe crab using a parasitic protozoan expressing the Factor C protein. In particular, the present invention provides a parasitic protozoan host cell harbouring a polynucleotide encoding horseshoe crab Factor C protein, and a method for producing Factor C protein comprising culturing said parasitic protozoan host cell under conditions such that the cells express the horseshoe crab Factor C protein. Furthermore, the present invention provides recombinant Factor C protein produced by the novel method and its use in the detection and/or removal of endotoxin.Type: GrantFiled: May 1, 2019Date of Patent: August 24, 2021Assignee: BIOMÉRIEUX DEUTSCHLAND GMBHInventors: Bernd Buchberger, Holger Grallert, Sonja Molinaro
-
Patent number: 11092592Abstract: The invention relates to unmasking endotoxins in compositions so that previously present, but undetectable endotoxins are rendered detectable.Type: GrantFiled: January 30, 2020Date of Patent: August 17, 2021Assignee: BIOMÉRIEUX DEUTSCHLAND GMBHInventor: Bernd Buchberger
-
Patent number: 10655113Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonisation and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.Type: GrantFiled: April 22, 2019Date of Patent: May 19, 2020Assignee: HYPHARM GMBHInventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger
-
Patent number: 10585086Abstract: The invention relates to unmasking endotoxins in compositions so that previously present, but undetectable endotoxins are rendered detectable.Type: GrantFiled: June 12, 2015Date of Patent: March 10, 2020Assignee: HYGLOS INVEST GMBHInventor: Bernd Buchberger
-
Patent number: 10323238Abstract: The present invention provides a novel method for the recombinant production of Factor C protein from horseshoe crab using a parasitic protozoan expressing the Factor C protein. In particular, the present invention provides a parasitic protozoan host cell harbouring a polynucleotide encoding horseshoe crab Factor C protein, and a method for producing Factor C protein comprising culturing said parasitic protozoan host cell under conditions such that the cells express the horseshoe crab Factor C protein. Furthermore, the present invention provides recombinant Factor C protein produced by the novel method and its use in the detection and/or removal of endotoxin.Type: GrantFiled: June 28, 2017Date of Patent: June 18, 2019Assignee: HYGLOS INVEST GMBHInventors: Bernd Buchberger, Holger Grallert, Sonja Molinaro
-
Patent number: 10301607Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonization and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.Type: GrantFiled: January 20, 2016Date of Patent: May 28, 2019Assignee: HYPHARM GMBHInventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger
-
Patent number: 9725706Abstract: The present invention provides a novel method for the recombinant production of Factor C protein from horseshoe crab using a parasitic protozoan expressing the Factor C protein. In particular, the present invention provides a parasitic protozoan host cell harboring a polynucleotide encoding horseshoe crab Factor C protein, and a method for producing Factor C protein comprising culturing said parasitic protozoan host cell under conditions such that the cells express the horseshoe crab Factor C protein. Furthermore, the present invention provides recombinant Factor C protein produced by the novel method and its use in the detection and/or removal of endotoxin.Type: GrantFiled: December 4, 2013Date of Patent: August 8, 2017Assignee: HYGLOS INVEST GMBHInventors: Bernd Buchberger, Holger Grallert, Sonja Molinaro
-
Patent number: 9453842Abstract: The present invention deals with reagents and compositions capable of effectively inhibiting peroxidase activity. According to the invention, peroxidase enzymatic activity is blocked with an acidic aqueous solution of a protein denaturing agent. Preferred protein denaturing agents are detergents and chaotropic substances.Type: GrantFiled: April 9, 2014Date of Patent: September 27, 2016Assignee: Roche Molecular Systems, Inc.Inventors: Manfred Watzele, Bernd Buchberger, Claudia Kirr
-
Publication number: 20160137993Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonisation and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.Type: ApplicationFiled: January 20, 2016Publication date: May 19, 2016Applicant: HYGLOS INVEST GMBHInventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger
-
Patent number: 9249447Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonization and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.Type: GrantFiled: June 17, 2011Date of Patent: February 2, 2016Assignee: HYGLOS INVEST GMBHInventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger
-
Patent number: 8951780Abstract: The invention concerns a method for isolating and purifying nucleic acids from large sample volumes and a device suitable for this. The device comprises a funnel, a separating column, and a tab which are detachable from each other. The method according to the invention in which the device according to the invention is used ensures a higher yield of nucleic acids.Type: GrantFiled: October 30, 2008Date of Patent: February 10, 2015Assignee: Roche Molecular Systems, Inc.Inventors: Maximilian Ruhstorfer, Bernd Buchberger, Horst Donner, Alois Rainer
-
Patent number: 8735083Abstract: The present invention deals with reagents and compositions capable of effectively inhibiting peroxidase activity. According to the invention, peroxidase enzymatic activity is blocked with an acidic aqueous solution of a protein denaturing agent. preferred protein denaturing agents are detergents and chaotropic substances.Type: GrantFiled: June 6, 2007Date of Patent: May 27, 2014Assignee: Roche Diagnostics Operations, Inc.Inventors: Manfred Watzele, Bernd Buchberger, Claudia Kirr
-
Publication number: 20130288926Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonisation and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.Type: ApplicationFiled: June 17, 2011Publication date: October 31, 2013Applicant: HYGLOS INVEST GMBHInventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger
-
Patent number: 8062843Abstract: The invention provides the use of water-miscible liquid cyclic acetals for adsorbing a nucleic acid to a solid phase such as a substrate with a silica surface. To this end, the invention also provides compositions comprising said acetals. Methods are disclosed and claimed to purify nucleic acids from samples, as well as kits useful for performing these methods. The nucleic acids purified by a method of the invention are suited for assays aiming at the detection of a target nucleic acid.Type: GrantFiled: June 9, 2009Date of Patent: November 22, 2011Assignee: Roche Diagnostics Operations, Inc.Inventors: Horst Donner, Frank Bergmann, Nina Lassonczyk, Bernd Buchberger
-
Publication number: 20100256349Abstract: The invention concerns a method for isolating and purifying nucleic acids from large sample volumes and a device suitable for this. The device comprises a funnel, a separating column, and a tab which are detachable from each other. The method according to the invention in which the device according to the invention is used ensures a higher yield of nucleic acids.Type: ApplicationFiled: October 30, 2008Publication date: October 7, 2010Inventors: Maximilian Ruhstorfer, Bernd Buchberger, Horst Donner, Alois Rainer
-
Publication number: 20100204050Abstract: The present invention provides a method for the isolation and analysis of a target nucleic acid, the target nucleic acid being present in a sample of genomic DNA, comprising the steps of a) fragmentation of the genomic DNA, b) hybridization of the genomic DNA on a nucleic acid solid support, the solid support comprising a plurality of oligonucleotide probes, the probes being characterized in that each probe is at least partially complementary to the sequence of the target nucleic acid or its complement, under hybridization conditions, characterized in that the plurality of probes hybridizes to fragments of the target nucleic acid but does not hybridize to other nucleic acids which are present in the sample, c) stripping off the target molecules hybridized to the nucleic acid array, d) overlap extension synthesis in order to generate double stranded overlap extension synthesis product, e) fragment polishing, and f) adaptor ligation.Type: ApplicationFiled: January 19, 2010Publication date: August 12, 2010Inventors: Horst Donner, Bernd Buchberger
-
Patent number: 7767292Abstract: The invention relates to a fired, fire resistant (refractory) ceramic product.Type: GrantFiled: March 22, 2006Date of Patent: August 3, 2010Assignee: Refractory Intellectual Property GmbH & Co. KGInventors: Boro Djuricic, Bernd Buchberger, Klaus Santowski, Franz Koeck
-
Publication number: 20100086923Abstract: The invention provides the use of water-miscible liquid cyclic acetals for adsorbing a nucleic acid to a solid phase such as a substrate with a silica surface. To this end, the invention also provides compositions comprising said acetals. Methods are disclosed and claimed to purify nucleic acids from samples, as well as kits useful for performing these methods. The nucleic acids purified by a method of the invention are suited for assays aiming at the detection of a target nucleic acid.Type: ApplicationFiled: June 9, 2009Publication date: April 8, 2010Inventors: Horst Donner, Frank Bergmann, Nina Lassonczyk, Bernd Buchberger
-
Publication number: 20090304673Abstract: The present invention relates to a method of treatment of an inflammatory disease, in particular sepsis, in particular sepsis caused by gram-positive bacteria, wherein the method comprises the step of administering to a subject in need thereof a sufficient amount of bacterial cell wall degrading enzymes. The present invention relates further to pharmaceutical compositions comprising bacterial cell wall degrading enzymes.Type: ApplicationFiled: June 10, 2009Publication date: December 10, 2009Inventors: Bernd Buchberger, Holger Grallert, Ingrid Wanninger
-
Patent number: 7528085Abstract: The invention relates to a fired refractory ceramic product and a batch that can be used to produce said product. Both the batch (the mixture) and the prepared fired product contain spinels consisting of MgO and Al2O3.Type: GrantFiled: January 19, 2005Date of Patent: May 5, 2009Assignee: Refractory Intellectual Property GmbH & Co. KGInventors: Bernd Buchberger, Roland Nilica